Alumis Inc. Common Stock (ALMS)
USD 8.89
(4.1%)
USD 8.89
(4.1%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 30.86 Million USD | 6479.96% |
| 2022 | 469 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 30.05 Million USD | 0.0% |
| 2024 Q1 | 30.45 Million USD | 0.0% |
| 2023 FY | 30.86 Million USD | 6479.96% |
| 2023 Q1 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | 56.671% |
| Alkermes plc | 287.73 Million USD | 89.275% |
| Agenus Inc. | 137.32 Million USD | 77.528% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 98.683% |
| Aptorum Group Limited | 3.05 Million USD | -908.991% |
| Ardelyx, Inc. | 51.54 Million USD | 40.132% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | 70.499% |
| Bicycle Therapeutics plc | 40.08 Million USD | 23.004% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | 69.323% |
| ChromaDex Corporation | 2.57 Million USD | -1098.447% |
| Chimerix, Inc. | 125 Thousand USD | -24588.0% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -852.872% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -19.114% |
| CRISPR Therapeutics AG | 223 Million USD | 86.162% |
| Precision BioSciences, Inc. | 7.72 Million USD | -299.586% |
| Dyadic International, Inc. | 88.87 Thousand USD | -34624.879% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -140172.727% |
| Fortress Biotech, Inc. | 60.85 Million USD | 49.29% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -50082.126% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -711.892% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -34141.711% |
| Incyte Corporation | 29.16 Million USD | -5.823% |
| IO Biotech, Inc. | 1.83 Million USD | -1578.086% |
| Jaguar Health, Inc. | 30.99 Million USD | 0.429% |
| Novavax, Inc. | 168.01 Million USD | 81.633% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -34.028% |
| Opthea Limited | 200.53 Million USD | 84.611% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -436.229% |
| ContextLogic Inc. | 6 Million USD | -414.333% |
| MiMedx Group, Inc. | 48.09 Million USD | 35.841% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -53.54% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -80493.351% |
| NextCure, Inc. | 5.94 Million USD | -418.743% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -21182.759% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -39.569% |
| PDS Biotechnology Corporation | 19.5 Million USD | -58.206% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | 73.277% |
| Pharming Group N.V. | 166.1 Million USD | 81.421% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -396.7% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | 7.922% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -2458.872% |
| Acelyrin, Inc. | 1.19 Million USD | -2484.59% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -6608.696% |
| Summit Therapeutics Inc. | 103.29 Million USD | 70.123% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -718.785% |
| Senti Biosciences, Inc. | 33.53 Million USD | 7.985% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -546.554% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | 10.696% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | 48.84% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -1865.605% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -21.477% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | 70.423% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -4115.847% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -175.757% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | 77.687% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -129.63% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -105.733% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | 83.837% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | 41.395% |
| Fortress Biotech, Inc. | 60.85 Million USD | 49.29% |
| Precigen, Inc. | 5.89 Million USD | -423.494% |
| Clearside Biomedical, Inc. | 41.98 Million USD | 26.503% |
| AlloVir, Inc. | 16.64 Million USD | -85.368% |
| C4 Therapeutics, Inc. | 65.75 Million USD | 53.07% |
| Fate Therapeutics, Inc. | 97.36 Million USD | 68.303% |
| ImmuCell Corporation | 10.54 Million USD | -192.776% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -2643.111% |
| Onconetix, Inc. | 118.85 Thousand USD | -25863.974% |
| PureTech Health plc | 18.25 Million USD | -69.096% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -31071.717% |
| Elevation Oncology, Inc. | 30.13 Million USD | -2.399% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -18.857% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | 28.022% |
| Innoviva, Inc. | 446.23 Million USD | 93.084% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -3604.682% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -46067.195% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | 85.089% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | 56.655% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -868.005% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -2873.025% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -38.224% |
| Aptose Biosciences Inc. | 621 Thousand USD | -4869.404% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -2952.623% |
| Century Therapeutics, Inc. | 46.65 Million USD | 33.859% |
| Kura Oncology, Inc. | 9.33 Million USD | -230.69% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -15.581% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -22262.319% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -228.823% |
| Autolus Therapeutics plc | 47.91 Million USD | 35.593% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -529.026% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -355.633% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | 76.381% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -280.753% |
| IGM Biosciences, Inc. | 34.67 Million USD | 10.994% |
| INmune Bio, Inc. | 397 Thousand USD | -7673.3% |
| Heron Therapeutics, Inc. | 173.75 Million USD | 82.239% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -661.175% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -20900.483% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | 37.997% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | 43.449% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | 32.462% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 93.481% |
| Verastem, Inc. | 40.08 Million USD | 23.016% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -601.045% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -206.943% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -370.355% |
| Histogen Inc. | 4.38 Million USD | -603.923% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -3398.866% |
| Organovo Holdings, Inc. | 888 Thousand USD | -3375.225% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -2.867% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -635.813% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -63.324% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | 59.234% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -33045.73% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -19.118% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -11458.052% |
| Amarin Corporation plc | 8.73 Million USD | -253.21% |
| Mesoblast Limited | 100.48 Million USD | 69.288% |
| Turnstone Biologics Corp. | 1.18 Million USD | -2495.458% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | 60.602% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -28211.927% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | 62.37% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | 83.753% |
| Better Therapeutics, Inc. | 10.34 Million USD | -198.222% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -33.449% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | 66.829% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -2288.545% |
| Gritstone bio, Inc. | 40.14 Million USD | 23.127% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -1601.213% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | 79.908% |
| Insmed Incorporated | 1.19 Billion USD | 97.414% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -385.984% |
| OmniAb, Inc. | 22.07 Million USD | -39.796% |
| Alector, Inc. | 30.45 Million USD | -1.327% |
| Seres Therapeutics, Inc. | 101.54 Million USD | 69.609% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -283.497% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 92.766% |
| Aura Biosciences, Inc. | 16.87 Million USD | -82.928% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | 45.759% |
| Immunic, Inc. | 639 Thousand USD | -4729.421% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -3.491% |
| Veracyte, Inc. | 7.52 Million USD | -310.1% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 95.215% |
| FibroGen, Inc. | 89.69 Million USD | 65.595% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -611.552% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -23481.914% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 99.396% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -83305.405% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -1458.586% |
| TG Therapeutics, Inc. | 100.11 Million USD | 69.176% |
| Galecto, Inc. | 66 Thousand USD | -46657.576% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -22591.176% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 98.11% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -413.051% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -471.799% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -1601.213% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -43.89% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | 15.579% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -5869.052% |
| Theravance Biopharma, Inc. | 45.23 Million USD | 31.78% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -0.935% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | 31.119% |
| Vaxxinity, Inc. | 13.26 Million USD | -132.695% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 96.196% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -6772.24% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -251.121% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 98.858% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -9665.823% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -592.239% |
| Ainos, Inc. | 5.92 Million USD | -421.147% |
| Pluri Inc. | 29.05 Million USD | -6.22% |
| Prothena Corporation plc | 10.72 Million USD | -187.846% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -55.458% |
| Celularity Inc. | 26.17 Million USD | -17.89% |
| Rallybio Corporation | 173 Thousand USD | -17738.15% |
| Cue Biopharma, Inc. | 4.2 Million USD | -634.412% |
| MeiraGTx Holdings plc | 72.11 Million USD | 57.21% |
| Omeros Corporation | 329.7 Million USD | 90.64% |
| Humacyte, Inc. | 38.6 Million USD | 20.052% |
| Immunocore Holdings plc | 82.64 Million USD | 62.659% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -1813.205% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -762.734% |
| Blueprint Medicines Corporation | 610.96 Million USD | 94.949% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -2016.598% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | 67.58% |
| Scholar Rock Holding Corporation | 48.68 Million USD | 36.612% |
| Sana Biotechnology, Inc. | 90.9 Million USD | 66.051% |
| Pulmatrix, Inc. | 8.32 Million USD | -270.602% |
| Elicio Therapeutics, Inc. | 6 Million USD | -413.734% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -138.393% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | 68.102% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -6479.957% |
| Cytokinetics, Incorporated | 607.37 Million USD | 94.919% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -255.039% |
| Nutriband Inc. | 79.82 Thousand USD | -38559.084% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -588.225% |
| Vor Biopharma Inc. | 31.83 Million USD | 3.047% |
| Roivant Sciences Ltd. | 477.85 Million USD | 93.542% |
| Evogene Ltd. | 10.65 Million USD | -189.684% |
| ProKidney Corp. | 3.61 Million USD | -754.848% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -3965.876% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -117122.518% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 98.222% |
| CorMedix Inc. | 517.01 Thousand USD | -5868.902% |
| BioLineRx Ltd. | 6.62 Million USD | -365.6% |
| Tango Therapeutics, Inc. | 36.83 Million USD | 16.228% |
| Galectin Therapeutics Inc. | 71.74 Million USD | 56.984% |
| Atai Life Sciences N.V. | 15.21 Million USD | -102.879% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -3563.391% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -12001.961% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | 28.482% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -7414.732% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -2154.2% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -4553.905% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | 82.67% |
| Biomea Fusion, Inc. | 7.83 Million USD | -294.125% |
| PTC Therapeutics, Inc. | 284.21 Million USD | 89.142% |
| Mereo BioPharma Group plc | 5.3 Million USD | -482.264% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -1335.349% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -5148.299% |
| Absci Corporation | 4.66 Million USD | -562.232% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -167.835% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -35.977% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -208.446% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -168.231% |
| Allakos Inc. | 38.21 Million USD | 19.246% |
| Imunon, Inc. | 1.13 Million USD | -2608.697% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -257.631% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -3591.388% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -308500.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | 65.069% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -555.341% |
| XOMA Corporation | 118.51 Million USD | 73.962% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -206.485% |
| Cara Therapeutics, Inc. | 37.07 Million USD | 16.772% |
| aTyr Pharma, Inc. | 13.76 Million USD | -124.159% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -290.682% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -23.618% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -52.734% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -205633.333% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -10993.138% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -113.492% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 97.942% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -22562.349% |
| UroGen Pharma Ltd. | 98.55 Million USD | 68.686% |
| Sutro Biopharma, Inc. | 149.11 Million USD | 79.304% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -61.85% |
| Entera Bio Ltd. | 256 Thousand USD | -11954.688% |
| GH Research PLC | 631 Thousand USD | -4790.65% |
| Lisata Therapeutics, Inc. | 137.00 USD | -22525447.445% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -4706.854% |
| Xencor, Inc. | 14.64 Million USD | -110.764% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -20438.965% |
| Replimune Group, Inc. | 71.99 Million USD | 57.133% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -20473.333% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -340.48% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -22562.349% |
| Portage Biotech Inc. | 7000.00 USD | -440757.143% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -4553.905% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -2059.552% |
| OncoCyte Corporation | 2.2 Million USD | -1300.181% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -46025.103% |
| Purple Biotech Ltd. | 163 Thousand USD | -18832.515% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -1117.357% |
| scPharmaceuticals Inc. | 38.81 Million USD | 20.486% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -22.247% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -42173.973% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -1565.407% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -17.125% |
| Curis, Inc. | 1.48 Million USD | -1972.532% |
| Daré Bioscience, Inc. | 3.91 Million USD | -688.517% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -4323.009% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -514233.333% |
| BeiGene, Ltd. | 197.61 Million USD | 84.384% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -3285.628% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | 61.7% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | 40.527% |
| bluebird bio, Inc. | 224.41 Million USD | 86.249% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 94.797% |
| DBV Technologies S.A. | 4.52 Million USD | -581.838% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -2202.985% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -216.773% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -719.22% |
| Travere Therapeutics, Inc. | 377.26 Million USD | 91.82% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | 28.027% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -1697.321% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -3225.431% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -76.676% |
| MacroGenics, Inc. | 30.19 Million USD | -2.199% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -74.321% |
| Prime Medicine, Inc. | 4.35 Million USD | -608.286% |
| Aditxt, Inc. | 1.04 Million USD | -2862.34% |
| Adagene Inc. | 13.54 Million USD | -127.917% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -124.649% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 94.051% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -80.542% |
| SciSparc Ltd. | 24 Thousand USD | -128483.333% |
| Vericel Corporation | 81.85 Million USD | 62.3% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | 62.374% |
| Generation Bio Co. | 89.77 Million USD | 65.625% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -39.103% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | 84.708% |
| Invivyd, Inc. | 722 Thousand USD | -4174.238% |
| Relay Therapeutics, Inc. | 48.5 Million USD | 36.374% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -1055401.021% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -706.797% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -134073.913% |
| 2seventy bio, Inc. | 244.01 Million USD | 87.353% |
| ADMA Biologics, Inc. | 130.59 Million USD | 76.37% |
| Clene Inc. | 7.15 Million USD | -331.488% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -814.029% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | 87.537% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -2702.906% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -11639.866% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | 83.979% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -8.65% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -220.158% |
| Vir Biotechnology, Inc. | 111.67 Million USD | 72.366% |
| Evaxion Biotech A/S | 8.48 Million USD | -263.54% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | 58.812% |
| Verve Therapeutics, Inc. | 64.71 Million USD | 52.314% |
| Trevena, Inc. | 35.23 Million USD | 12.412% |
| Surrozen, Inc. | 882 Thousand USD | -3398.866% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -396.461% |
| Cingulate Inc. | 135.09 Thousand USD | -22742.508% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -31.102% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | 35.439% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -17044.444% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -21.597% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -76.98% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -3197.009% |
| Statera Biopharma, Inc. | 11.43 Million USD | -169.964% |
| ImmunityBio, Inc. | 836.95 Million USD | 96.313% |
| Korro Bio, Inc. | 31.21 Million USD | 1.14% |
| Kineta, Inc. | 150 Thousand USD | -20473.333% |
| BioVie Inc. | 349.89 Thousand USD | -8719.814% |
| Codexis, Inc. | 12.24 Million USD | -152.062% |
| Celularity Inc. | 26.17 Million USD | -17.89% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | 35.107% |
| Celcuity Inc. | 37.03 Million USD | 16.674% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -17399.787% |
| Cibus, Inc. | 17.67 Million USD | -74.607% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -813.288% |
| Kodiak Sciences Inc. | 100 Million USD | 69.14% |
| Annexon, Inc. | 29.19 Million USD | -5.721% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | 52.249% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -2650.446% |
| Avalo Therapeutics, Inc. | 2 Million USD | -1443.0% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 97.796% |
| Eyenovia, Inc. | 8.95 Million USD | -244.526% |
| Puma Biotechnology, Inc. | 65.65 Million USD | 53.0% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -279.022% |
| Arcellx, Inc. | 50.84 Million USD | 39.301% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -2016.598% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -45.306% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -2825.118% |
| Moolec Science SA | 99.04 Thousand USD | -31057.24% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -11.727% |
| Geron Corporation | 35.05 Million USD | 11.957% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -5121.658% |
| Royalty Pharma plc | 6.13 Billion USD | 99.497% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -1779.415% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -97121.347% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -33.316% |
| Humacyte, Inc. | 38.6 Million USD | 20.052% |
| Structure Therapeutics Inc. | 4.01 Million USD | -669.001% |
| 89bio, Inc. | 24.79 Million USD | -24.461% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -148.19% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -1553.805% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -2890.31% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | 68.987% |
| Notable Labs, Ltd. | 1.52 Million USD | -1922.28% |
| Liquidia Corporation | 2.36 Million USD | -1205.415% |
| Mustang Bio, Inc. | 1.97 Million USD | -1460.162% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -124.649% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -343.837% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -9635.016% |
| Vera Therapeutics, Inc. | 49.87 Million USD | 38.128% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -221.324% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -47022.418% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -22591.176% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -392.656% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -23638.462% |
| PepGen Inc. | 17.1 Million USD | -80.468% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -6410.549% |
| United Therapeutics Corporation | 300 Million USD | 89.713% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -28.9% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -641.319% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -5239.1% |
| XOMA Corporation | 118.51 Million USD | 73.962% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -83305.405% |
| Bionomics Limited | 117.62 Million USD | 73.765% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -3207.61% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -450.089% |
| uniQure N.V. | 130.06 Million USD | 76.273% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | 47.329% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -4398.542% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -611.552% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -2128.159% |
| Altimmune, Inc. | 175 Thousand USD | -17534.286% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | 92.043% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -450.089% |
| Compugen Ltd. | 719 Thousand USD | -4192.072% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -509.159% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | 63.503% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -210.775% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -383.775% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | 66.24% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -210.775% |
| Instil Bio, Inc. | 81.42 Million USD | 62.101% |
| argenx SE | 15.35 Million USD | -100.99% |
| Immunome, Inc. | 1.34 Million USD | -2202.985% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -5657.463% |
| Verona Pharma plc | 48.37 Million USD | 36.205% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -234.852% |
| Shattuck Labs, Inc. | 3.4 Million USD | -806.048% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -36205.882% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -18269.048% |
| Moolec Science SA | 99.04 Thousand USD | -31057.24% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -179.73% |
| AnaptysBio, Inc. | 16.03 Million USD | -92.43% |
| Design Therapeutics, Inc. | 2.33 Million USD | -1222.194% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -113896.528% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -414.333% |
| Achilles Therapeutics plc | 1.07 Million USD | -2768.03% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -234.852% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -154695.345% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -84.322% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -38559.084% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -413517.478% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -237284.615% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | 90.989% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -26.041% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -1134.405% |
| Palisade Bio, Inc. | 90 Thousand USD | -34188.889% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -15807.216% |
| Beam Therapeutics Inc. | 159.91 Million USD | 80.702% |
| Neurogene Inc. | 13.37 Million USD | -130.763% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | 89.929% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -17.504% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -51486.373% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -2986.0% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | 23.818% |
| Athira Pharma, Inc. | 1.21 Million USD | -2435.744% |
| Vaccinex, Inc. | 26 Thousand USD | -118592.308% |
| HCW Biologics Inc. | 6.3 Million USD | -389.506% |
| XOMA Corporation | 118.51 Million USD | 73.962% |
| Nektar Therapeutics | 112.62 Million USD | 72.599% |
| Arvinas, Inc. | 800 Thousand USD | -3757.5% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -113.492% |
| Merus N.V. | 10.48 Million USD | -194.241% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -107.323% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -129.801% |
| Rezolute, Inc. | 1.66 Million USD | -1759.036% |
| Clene Inc. | 7.15 Million USD | -331.488% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -41973.404% |
| BeyondSpring Inc. | 3.36 Million USD | -817.36% |
| Synlogic, Inc. | 12.49 Million USD | -147.058% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | 5.5% |
| Krystal Biotech, Inc. | 6.62 Million USD | -366.163% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | 81.945% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -414.676% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -65045.342% |
| MannKind Corporation | 252.15 Million USD | 87.761% |
| Ikena Oncology, Inc. | 7.18 Million USD | -329.805% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -15407.538% |
| Gossamer Bio, Inc. | 197.4 Million USD | 84.367% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -5834.615% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | 89.031% |
| Mural Oncology plc | 8.91 Million USD | -246.314% |
| Biora Therapeutics, Inc. | 43.73 Million USD | 29.44% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -2049.025% |
| Champions Oncology, Inc. | 6.09 Million USD | -406.483% |
| REGENXBIO Inc. | 82.22 Million USD | 62.467% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -6146.926% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -595.986% |
| Vaxart, Inc. | 2.62 Million USD | -1076.515% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -11261.001% |
| Cellectis S.A. | 36.24 Million USD | 14.848% |
| Longeveron Inc. | 1.44 Million USD | -2031.215% |
| Repare Therapeutics Inc. | 1.01 Million USD | -2955.446% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 97.275% |
| Inozyme Pharma, Inc. | 44.76 Million USD | 31.068% |
| Revolution Medicines, Inc. | 80.57 Million USD | 61.7% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -861.97% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -17335.028% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -24989.431% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 95.742% |
| Denali Therapeutics Inc. | 44.98 Million USD | 31.393% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -146.796% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -22742.508% |
| Passage Bio, Inc. | 22.92 Million USD | -34.636% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -411.012% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -4669.706% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -53.037% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -6197.959% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -7473.805% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -2497.643% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -6522.318% |
| OmniAb, Inc. | 22.07 Million USD | -39.796% |
| Anew Medical, Inc. | 1.54 Million USD | -1903.896% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -4.398% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -241.636% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | 0.74% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -661.175% |
| G1 Therapeutics, Inc. | 51.55 Million USD | 40.144% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -384.687% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -118.416% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -4492.262% |
| Equillium, Inc. | 384 Thousand USD | -7936.458% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -401.055% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | 79.57% |
| Evelo Biosciences, Inc. | 48.87 Million USD | 36.865% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -25552.109% |
| Dominari Holdings Inc. | 3.02 Million USD | -919.155% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -155971.411% |
| vTv Therapeutics Inc. | 169 Thousand USD | -18160.355% |
| Bio-Techne Corporation | 319 Million USD | 90.326% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | 45.848% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | 82.718% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -100.299% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -149.213% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -541.98% |
| Nkarta, Inc. | 82.27 Million USD | 62.489% |
| BioCardia, Inc. | 982 Thousand USD | -3042.566% |
| Iterum Therapeutics plc | 18.95 Million USD | -62.798% |